Edwards Lifesciences Corp officer Donald E. Bobo Jr. filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 48,900 shares of common stock through a cashless employee stock option exercise.
Key Highlights
- Proposed shares: 48,900 shares of Edwards Lifesciences common stock are proposed to be sold.
- Aggregate market value: The filing states an aggregate market value of $5,039,313.00 for the proposed sale.
- Acquisition method: Shares were acquired on November 9, 2026, via an employee stock option exercise, with payment described as a broker payment for cashless exercise.
- 10b5-1 plan: According to the filing, a Rule 10b5-1 trading plan was adopted on February 12, 2026.
- No sales in prior three months: The filing reports nothing to report for securities sold during the past three months.
- Shares outstanding: The filing lists 575,000,000 shares of common stock outstanding.
- Broker: Charles Schwab & Co., Inc., located in Westlake, TX, is named as the broker for the proposed sale.
Bobo Jr. Discloses Proposed Stock Sale Under Rule 144 at Edwards Lifesciences
Edwards Lifesciences Corp (NYSE:EW) officer Donald E. Bobo Jr. submitted a Form 144 notice of proposed sale of securities on November 9, 2026, according to the filing. The notice covers 48,900 shares of the company's common stock, with an approximate sale date of November 9, 2026, and a stated aggregate market value of $5,039,313.00.
According to the filing, the shares were acquired through an employee stock option exercise from Edwards Lifesciences Corporation on November 9, 2026, with payment made via a broker payment for a cashless exercise. The filing identifies Bobo Jr.'s relationship to the issuer as "Officer." The proposed sale is to be executed through Charles Schwab & Co., Inc. on the NYSE, the filing states.
The filing notes that the transaction is being conducted pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2026. The filing also indicates that no securities of the issuer were sold by the reporting person during the three months preceding this notice. Edwards Lifesciences' issuer address is listed as One Edwards Way, Irvine, California 92614.
What Was Disclosed
Edwards Lifesciences officer Donald E. Bobo Jr. filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 48,900 common shares with an aggregate market value of $5,039,313.00, acquired through a cashless stock option exercise under a pre-established 10b5-1 plan.



Please wait processing your request...